+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucose Monitoring Devices Market - Global Forecast 2026-2032- Product Image
Glucose Monitoring Devices Market - Global Forecast 2026-2032- Product Image
Sale

Glucose Monitoring Devices Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532692
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glucose Monitoring Devices Market is projected to reach USD 10.36 Billion in 2026. It is expected to continue growing at a CAGR of 12.81%, reaching USD 21.74 Billion by 2032.

Glucose monitoring devices are becoming core infrastructure for diabetes management, moving beyond episodic finger-stick testing toward connected, continuous, and clinically actionable glucose data. The public health need is well documented: the World Health Organization estimates that diabetes affected about 830 million people globally in 2022.

The market includes self-monitoring blood glucose meters, test strips, continuous glucose monitoring systems, flash glucose monitoring sensors, integrated CGM platforms, wearable transmitters, mobile applications, and remote patient monitoring workflows. Growth is supported by aging populations, rising type 2 diabetes prevalence, expanded insulin use, broader reimbursement, and the proven clinical value of time-in-range metrics for reducing glycemic variability and improving diabetes care decisions.

Transformative Shifts in the Glucose Monitoring Landscape

The glucose monitoring devices landscape is shifting from reactive measurement to continuous, preventive diabetes care. Continuous glucose monitoring is increasingly embedded in treatment guidelines, with the American Diabetes Association supporting CGM use across many people with type 1 diabetes and insulin-treated type 2 diabetes. In the United States, the Centers for Medicare & Medicaid Services expanded CGM coverage in 2023 to include more insulin users and selected people with problematic hypoglycemia, reinforcing the move from niche technology to standard care.

Regulatory and technology changes are also transforming competition. The U.S. FDA created the integrated continuous glucose monitoring pathway to support interoperable sensors, while Europe’s Medical Device Regulation has raised evidence and post-market surveillance expectations. At the same time, smartphone connectivity, cloud analytics, smaller sensors, longer wear times, pharmacy distribution, and remote patient monitoring are improving access, adherence, and patient engagement.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of glucose monitoring devices by converting continuous sensor readings into predictive, personalized, and workflow-ready insights. AI-enabled analytics can support glucose trend forecasting, hypoglycemia and hyperglycemia risk alerts, meal and activity pattern recognition, sensor quality checks, population-level risk stratification, and clinician prioritization in remote monitoring programs. These capabilities are especially relevant as CGM adoption increases the volume of real-world glucose data available for care decisions.

The cumulative impact is a transition from device-centric monitoring to decision-support ecosystems. In automated insulin delivery, glucose sensors already work with control algorithms and insulin pumps to adjust insulin delivery within regulated systems. Industry leaders must pair AI innovation with clinical validation, explainability, cybersecurity, bias testing, human factors evidence, and compliance with software-as-a-medical-device expectations from regulators such as the FDA and European authorities.

Key Regional Insights

Asia-Pacific is a high-priority region because China and India account for some of the world’s largest diabetes populations, while Japan, Australia, and South Korea show stronger adoption of advanced CGM through specialist care, digital health infrastructure, diabetes education networks, and reimbursement pathways. North America remains a leading innovation and adoption hub, supported by FDA-cleared technologies, CMS coverage expansion, strong endocrinology networks, pharmacy access, and high awareness of time-in-range management.

Latin America is advancing through private healthcare channels and public-sector diabetes initiatives, with Brazil and Mexico serving as major demand centers for both blood glucose meters and continuous glucose monitoring. Europe benefits from structured diabetes care, CE-marked innovation, national reimbursement decisions, and guideline-driven adoption, although country-level access varies due to health technology assessment and regional purchasing models. The Middle East faces a high diabetes burden, particularly in Gulf economies, creating demand for premium monitoring, digital diabetes clinics, and remote care models. Africa remains access-constrained, with opportunities centered on affordable blood glucose meters, reliable test-strip supply, clinician training, patient education, and scalable mobile health support.

Key Group Insights

ASEAN demand is shaped by rising type 2 diabetes prevalence, expanding urban healthcare access, growing pharmacy networks, and uneven reimbursement, making affordability, education, and distributor partnerships critical. The GCC has high diabetes prevalence and well-funded health systems, supporting adoption of CGM, digital diabetes clinics, preventive screening, and connected care programs. The European Union is influenced by MDR compliance, data protection rules, health technology assessment, national reimbursement decisions, and cross-border digital health priorities.

BRICS markets combine scale with complexity: China and India offer large patient pools and local manufacturing momentum, Brazil expands access through mixed public-private channels, Russia faces procurement and supply constraints, and South Africa anchors demand in sub-Saharan Africa. G7 countries represent advanced reimbursement, regulatory maturity, clinical evidence generation, and early adoption of integrated diabetes technologies. NATO is not a diabetes policy bloc, but its member countries influence cybersecurity expectations, medical supply resilience, procurement discipline, and digital infrastructure standards relevant to connected glucose monitoring devices.

Key Country Insights

The United States leads in CGM innovation, reimbursement expansion, remote patient monitoring, and connected diabetes platforms, while Canada benefits from provincial coverage decisions and strong clinical adoption in type 1 diabetes. Mexico and Brazil show growing demand driven by diabetes prevalence, private care expansion, public health programs, and the need for affordable monitoring. In Europe, the United Kingdom is shaped by NHS guidance and NICE recommendations, Germany by statutory insurance pathways and digital health adoption, France by centralized reimbursement evaluation, Italy and Spain by regional health system purchasing, and Russia by localized procurement and supply-chain considerations.

In Asia-Pacific, China combines a very large diabetes population with domestic medtech manufacturing, hospital-led adoption, and expanding digital health infrastructure, while India requires cost-sensitive devices, broad distribution, clinician training, and education-led engagement to improve routine glucose testing. Japan is characterized by advanced healthcare infrastructure and aging-related diabetes needs, Australia by structured reimbursement and strong diabetes education networks, and South Korea by technology readiness, hospital integration, smartphone penetration, and digital health adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated CGM and blood glucose monitoring portfolios that address both premium and affordability segments. Interoperability with insulin pumps, electronic health records, mobile applications, pharmacy workflows, and remote patient monitoring platforms should be treated as a competitive requirement rather than an optional feature.

Companies should invest in AI governance, cybersecurity, post-market evidence, human factors testing, and real-world outcomes that demonstrate improved time in range, fewer hypoglycemic events, better adherence, and improved care-team efficiency. Market access strategies must be localized by reimbursement status, diabetes burden, pharmacy reach, clinician training needs, and digital infrastructure maturity, while supply-chain resilience for sensors, semiconductors, enzymes, adhesives, batteries, and test strips remains essential.

Research Methodology

Research methodology is based on secondary research and triangulation from authoritative public sources, including the World Health Organization, International Diabetes Federation, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, American Diabetes Association, NICE, OECD, World Bank health indicators, peer-reviewed clinical literature, and national diabetes or reimbursement bodies.

The methodology emphasizes verified epidemiology, regulatory developments, reimbursement policies, clinical guideline direction, technology adoption signals, and digital health readiness across regions and countries. Insights were synthesized using market-structure analysis, demand-driver assessment, technology trend evaluation, policy review, and geographic comparison to support leader-relevant and decision-ready content on glucose monitoring devices.

Conclusion

Glucose monitoring devices are central to the future of diabetes care as health systems shift toward continuous data, earlier intervention, and digitally connected chronic disease management. Rising diabetes prevalence, expanded CGM reimbursement, AI-enabled analytics, remote monitoring, and interoperability standards are strengthening the role of monitoring technologies in both clinical and home settings.

The strongest opportunities will belong to organizations that combine accurate sensors, affordable access, regulatory discipline, secure data ecosystems, reliable supply chains, and evidence-based outcomes. As adoption widens across developed and emerging markets, glucose monitoring devices will remain a foundational category in precision diabetes management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Glucose Monitoring Devices Market, by Product Type
7.1. Introduction
7.2. Self-Monitoring Blood Glucose (SMBG) Devices
7.2.1. Blood Glucose Meters
7.2.2. Test Strips
7.2.3. Lancets
7.3. Continuous Glucose Monitoring (CGM) Systems
7.3.1. Real-Time CGM
7.3.2. Intermittently Scanned CGM
7.3.3. Sensors
7.4. Professional / Clinical Point-of-Care Devices
7.5. Non-Invasive Glucose Monitoring Devices
8. Glucose Monitoring Devices Market, by Technology
8.1. Introduction
8.2. Invasive
8.2.1. Colorimetric
8.2.2. Electrochemical Amperometric
8.3. Minimally Invasive
8.4. Non Invasive
8.4.1. Optical Spectroscopy
8.4.2. Transdermal Extraction
9. Glucose Monitoring Devices Market, by Application
9.1. Introduction
9.2. Gestational Diabetes
9.3. Type 1 Diabetes
9.4. Type 2 Diabetes
10. Glucose Monitoring Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Care
10.3. Home Care
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Glucose Monitoring Devices Market, by Distribution Channel
11.1. Introduction
11.2. Online Stores
11.2.1. Company Websites
11.2.2. E Commerce Platforms
11.3. Offline
12. Glucose Monitoring Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Glucose Monitoring Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Glucose Monitoring Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. ACON Laboratories, Inc.
16.3. AgaMatrix, Inc.
16.4. ARKRAY, Inc.
16.5. Ascensia Diabetes Care Holdings AG
16.6. B. Braun Melsungen AG
16.7. Beta Bionics, Inc.
16.8. Beurer GmbH
16.9. Bionime Corporation
16.10. Dexcom, Inc.
16.11. DiaMonTech AG
16.12. F. Hoffmann-La Roche Ltd
16.13. ForaCare, Inc.
16.14. GlySens Incorporated
16.15. i-SENS, Inc.
16.16. Insulet Corporation
16.17. LifeScan IP Holdings, LLC
16.18. Medtronic plc
16.19. MicroPort Scientific Corporation
16.20. Nemaura Medical Inc.
16.21. Nipro Corporation
16.22. Nova Biomedical Corporation
16.23. Novo Nordisk A/S
16.24. Omron Healthcare Co., Ltd.
16.25. Prodigy Diabetes Care, LLC
16.26. Rossmax International Ltd.
16.27. Sanofi S.A.
16.28. Senseonics Holdings, Inc.
16.29. Sinocare Inc.
16.30. TaiDoc Technology Corporation
16.31. Tandem Diabetes Care, Inc.
16.32. Terumo Corporation
16.33. Trividia Health, Inc.
16.34. WaveForm Technologies, Inc.
16.35. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL GLUCOSE MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LANCETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL REAL-TIME CGM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REAL-TIME CGM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REAL-TIME CGM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONLINE STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ONLINE STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ONLINE STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 132. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 135. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 136. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 138. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 139. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 142. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 143. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 156. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 159. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 160. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 162. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 163. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 166. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 167. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 172. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 173. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 174. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 175. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 176. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 179. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 181. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 184. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 185. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 187. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 188. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 191. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 192. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 205. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 208. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 209. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 211. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 212. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 215. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 217. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 220. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 221. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 223. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 224. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 227. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 228. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 229. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 232. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 233. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 235. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 236. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 239. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 241. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 254. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 257. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 258. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 260. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 261. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 264. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 265. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 266. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 269. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 270. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 271. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 272. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 273. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 276. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 277. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 281. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 288. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 289. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 302. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 305. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 306. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 308. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 309. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 312. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 314. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 317. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 318. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 319. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2017-2032 (USD MILLION)
TABLE 320. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2017-2032 (USD MILLION)
TABLE 321. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 324. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 325. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2017-2032 (USD MILLION)
TABLE 326. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2017-2032 (USD MILLION)
TABLE 329. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2017-2032 (USD MILLION)
TABLE 330. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION

Companies Mentioned

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beta Bionics, Inc.
  • Beurer GmbH
  • Bionime Corporation
  • Dexcom, Inc.
  • DiaMonTech AG
  • F. Hoffmann-La Roche Ltd
  • ForaCare, Inc.
  • GlySens Incorporated
  • i-SENS, Inc.
  • Insulet Corporation
  • LifeScan IP Holdings, LLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nemaura Medical Inc.
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Novo Nordisk A/S
  • Omron Healthcare Co., Ltd.
  • Prodigy Diabetes Care, LLC
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Senseonics Holdings, Inc.
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • WaveForm Technologies, Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.36 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.74 Billion
Compound Annual Growth Rate12.8%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Smart Blood Glucose Monitoring Device Market - Global Forecast 2026-2032 - Product Image

Smart Blood Glucose Monitoring Device Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032 - Product Image

Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Blood Glucose Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 236 Pages
  • Global
From
Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030 - Product Image

Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030

  • Report
  • 302 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.